Effect of High-dose Atorvastatin on the Short-term Prognosis of Acute STEMI Patients with Emergency PCI
1.Department of Cardiovascular,Suzhou Science & Technology Town Hospital/ Suzhou Hospital Affiliated to Nanjing Medical University,Suzhou 215153,China
2.Department of Cardiovascular,the Second Affiliated Hospital of Soochow University,Suzhou 215004,China
*Corresponding author:XU Wei-ting,Associate professor,Chief physician;E-mail:xuwt1968@aliyun.com
WANG Xue-bin,ZHAO Liang-ping,XU Wei-ting, et al. Effect of High-dose Atorvastatin on the Short-term Prognosis of Acute STEMI Patients with Emergency PCI[J]. Chinese General Practice, 2018, 21(26): 3164-3169. DOI: 10.3969/j.issn.1007-9572.2018.00.252.
王学斌,赵良平,徐卫亭等. 强化他汀治疗对急性ST段抬高型心肌梗死患者急诊经皮冠状动脉介入治疗术后近期预后的效果研究[J]. 中国全科医学, 2018, 21(26): 3164-3169. DOI: 10.3969/j.issn.1007-9572.2018.00.252.
[1]PASCERI V,PATTI G,NUSCA A,et al.Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention:results from the ARMYDA (Atorvastatin for Reduction of Myocardial Damage during Angioplasty) study[J].Circulation,2004,110(6):674-678.DOI:10.1161/01.CIR.0000137828.06205.87.3168
[2]PATTI G,PASCERI V,COLONNA G,et al.Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention:results of the ARMYDA-ACS randomized trial[J].J Am Coll Cardiol,2007,49(12):1272-1278.DOI:10.1016/j.jacc.2007.02.025.3168
[3]DI SCIASCIO G,PATTI G,PASCERI V,et al.Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention:results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage during Angioplasty) Randomized Trial[J].J Am Coll Cardiol,2009,54(6):558-565.DOI:10.1016/j.jacc.2009.05.028.3168
[4]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志,2010,38(8):675-687.DOI:10.3760/cma.j.issn.0253-3758.2010.08.002.3168
China Society of Cardiology,Editorial Board of Chinese Journal of Cardiology.Guidelines for the diagnosis and treatment of acute ST segment elevation myocardial infarction[J].Chinese Journal of Cardiology,2010,38(8):675-687.DOI:10.3760/cma.j.issn.0253-3758.2010.08.002.3168
[5]罗彤,杨跃进,宋蓉,等.首次心肌梗死患者878例冠状动脉病变的特点分析[J].中华医学杂志,2004,84(11):910-914.DOI:10.3760/j:issn:0376-2491.2004.11.009.3168
LUO T,YANG Y J,SONG R,et al.Coronary angiographic findings within 6 months after first myocardial infarction:a report of 878 cases[J].Chinese Medical Journal,2004,84(11):910-914.DOI:10.3760/j:issn:0376-2491.2004.11.009.3168
[6]吕安康,沈卫峰,张继盛,等.冠状动脉内支架植入成功与否对严重心脏事件发生的影响[J].中华心血管病杂志,2001,29(9):534-537.DOI:10.3760/j:issn:0253-3758.2001.09.008.3168
LYU A K,SHEN W F,ZHANG J S,et al.Risk factors related to major adverse cardiac events during intracoronary stenting[J].Chinese Journal of Cardiology,2001,29(9):534-537.DOI:10.3760/j:issn:0253-3758.2001.09.008.3168
[7]陈丽媛,严华,陆永光,等.造影剂肾病对冠状动脉粥样硬化性心脏病患者短期预后的影响[J].中国现代医学杂志,2016,26(8):71-75.DOI:10.3969/j.issn.1005-8982.2016.08.015.3168
CHEN L Y,YAN H,LU Y G,et al.Impact of contrast-induced nephropathy on short-term prognosis ofpatients with coronary heart disease[J].China Journal of Modern Medicine,2016,26(8):71-75.DOI:10.3969/j.issn.1005-8982.2016.08.015.3169
[8]CANNON C P,BRAUNWALD E,MCCABE C H,et al.Intensive versus moderate lipid lowering with statins after acute coronary syndromes[J].N Engl J Med,2004,350(15):1495-1504.DOI:10.1056/NEJMoa040583.3169
[9]SCHWARTZ G G,OLSSON A G,EZEKOWITZ M D,et al.Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes:the MIRACL study:a randomized controlled trial[J].JAMA,2001,285(13):1711-1718.3169
[10]PINHO-GOMES A C,REILLY S,BRANDES R P,et al.Targeting inflammation and oxidative stress in atrial fibrillation:role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins[J].Antioxid Redox Signal,2014,20(8):1268-1285.DOI:10.1089/ars.2013.5542.3169
[11]MAHALWAR R,KHANNA D.Pleiotropic antioxidant potential of rosuvastatin in preventing cardiovascular disorders[J].Eur J Pharmacol,2013,711(1/2/3):57-62.DOI:10.1016/j.ejphar.2013.04.025.3169
[12]ANTONOPOULOS A S,MARGARITIS M,SHIRODARIA C,et al.Translating the effects of statins:from redox regulation to suppression of vascular wall inflammation[J].Thromb Haemost,2012,108(5):840-848.DOI:10.1160/TH12-05-0337.3169
[13]FANG S Y,ROAN J N,LUO C Y,et al.Pleiotropic vascular protective effects of statins in perioperative medicine[J].Acta Anaesthesiol Taiwan,2013,51(3):120-126.DOI:10.1016/j.aat.2013.08.003.3169
[14]PURI R,LIBBY P,NISSEN S E,et al.Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition:insights from SATURN[J].Eur Heart J Cardiovascular Imaging,2014,15(4):380-388.DOI:10.1093/ehjci/jet251.3169
[15]BLUM A.HMG-CoA reductase inhibitors (statins),inflammation,and endothelial progenitor cells-new mechanistic insights of atherosclerosis[J].Biofactors,2014,40(3):295-302.DOI:10.1002/biof.1157.3169
[16]ANTóNIO N,FERNANDES R,SOARES A,et al.Impact of prior chronic statin therapy and high-intensity statin therapy at discharge on circulating endothelial progenitor cell levels in patients with acute myocardial infarction:a prospective observational study[J].Eur J Clin Pharmacol,2014,70(10):1181-1193.DOI:10.1007/s00228-014-1718-6.3169
[17]KIM J S,KIM J,CHOI D,et al.Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction:the STATIN STEMI trial[J].JACC Cardiovasc Interv,2010,3(3):332-339.DOI:10.1016/j.jcin.2009.11.021.3169
[18]BRIGUORI C,VISCONTI G,FOCACCIO A,et al.Novel approaches for preventing or limiting events (NAPLES) Ⅱ trial:impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction[J].J Am Coll Cardiol,2009,54(23):2157-2163.DOI:10.1016/j.jacc.2009.07.005.3169
[19]郭筱燕,黄学成,王琦武.不同负荷剂量阿托伐他汀钙对不稳定型心绞痛患者冠状动脉介入治疗术后的影响[J].中国动脉硬化杂志,2014,22(10):1039-1043.3169
GUO X Y,HUANG X C,WANG Q W.Effect of different loading doses of atorvastatin calcium on unstable angina pectoris patients after percutaneous coronary intervention[J].Chinese Journal of Arteriosclerosis,2014,22(10):1039-1043.3169
[20]STONE N J,ROBINSON J,LICHTENSTEIN A H,et al.2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J].J Am Coll Cardiol,2014,63(25 Pt B):2889-2934.DOI:10.1016/j.jacc.2013.11.002.3169
[21]中华医学会心血管病学分会.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志,2015,43(5):380-393.DOI:10.3760/cma.j.issn.0253-3758.2015.05.003.3169
Chinese Society of Cardiology.Guidelines for the diagnosis and treatment of acute ST segment elevation myocardial infarction[J].Chinese Journal of Cardiology,2015,43(5):380-393.DOI:10.3760/cma.j.issn.0253-3758.2015.05.003.3169
[22]ZHENG B,JIANG J,LIU H,et al.Efficacy and safety of serial atorvastatin load in Chinese patients undergoing elective percutaneous coronary intervention:results of the ISCAP(intensive statin therapy for Chinese patients with coronary artery disease undergoing percutaneous coronary intervention) randomized controlled trial[J].Euro Heart J,2015,17(suppl B):B47-56.DOI:10.1093/eurheartj/suv021.3169
[23]JANG Y,ZHU J,GE J,et al.Preloading with atorvastatin before percutaneous coronary intervention in statin-naive Asian patients with non-ST elevation acute coronary syndromes:a randomized study[J].J Cardiol,2014,63(5):335-343.DOI:10.1016/j.jjcc.2013.09.012.3169
[24]ZHAO S P,PENG D Q,YU B L,et al.The effect of moderate-dose versus double-dose statins on patients with acute coronary syndrome in China:results of the CHILLAS trial[J].Atherosclerosis,2014,233(2):707-712.DOI:10.1016/j.atherosclerosis.2013.12.003.3169
[25]中华医学会心血管病学分会介入心脏病学组,中国医师协会心血管内科医师分会,中华心血管病杂志编辑委员会.中国经皮冠状动脉介入治疗指南(2016)[J].中华心血管病杂志,2016,44(5):382-400.DOI:10.3760/cma.j.issn.0253-3758.2016.05.006.3169
Interventional Cardiology Group of Chinese Society of Cardiology,Chinese College of Cardiovascular Physicians,Editorial Board of Chinese Journal of Cardiology.Chinese guideline for percutaneous coronary intervention(2016)[J].Chinese Journal of Cardiology,2016,44(5):382-400.DOI:10.3760/cma.j.issn.0253-3758.2016.05.006.3169
[26]中国成人血脂异常防治指南修订联合委员会.中国成人血脂异常防治指南(2016年修订版)[J].中国循环杂志,2016,31(10):937-950.DOI:10.3969/j.issn.1000-3614.2016.10.001.3174
Joint Commission on the Prevention and Control of Dyslipidemia in Chinese Adults.Chinese guideline for prevention and treatment of dyslipidemia in adults(revised version 2016)[J].Chinese Circulation Journal,2016,31(10):937-950.DOI:10.3969/j.issn.1000-3614.2016.10.001.3174
[27]IBANEZ B,JAMES S,AGEWALL S,et al.2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology(ESC)[J].Eur Heart J,2018,39(2):119-177.DOI:10.1093/eurheartj/ehx393.3174
[28]ZHANG L,LI J,LI X,et al.National assessment of statin therapy in patients hospitalized with acute myocardial infarction:insight from China PEACE-retrospective AMI study,2001,2006,2011[J].PLoS One,2016,11(4):e0150806.DOI:10.1371/journal.pone.0150806.3174
[29]MORISHIMA I,SONE T,OKUMURA K,et al.Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction[J].J Am Coll Cardiol,2000,36(4):1202-1209.DOI:10.1016/S0735-1097(00)00865-2.3174
[30]RAMJANE K,HAN L,JIN C.The diagnosis and treatment of the no-reflow phenomenon in patients with myocardial infarction undergoing percutaneous coronary intervention[J].Exp Clin Cardiol,2008,13(3):121-128.3174
[31]ZHAO J L,YANG Y J,CUI C J,et al.Pretreatment with simvastatin reduces myocardial no-reflow by opening mitochondrial K(ATP) channel[J].Br J Pharmacol,2006,149(3):243-249.DOI:10.1038/sj.bjp.0706862.3174
[32]ZHOU S S,TIAN F,CHEN Y D,et al.Combination therapy reduces the incidence of no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction[J].J Geriatr Cardiol,2015,12(2):135-142.DOI:10.11909/j.issn.1671-5411.2015.02.003.3174
[33]LI X D,YANG Y J,HAO Y C,et al.Effect of pre-procedural statin therapy on myocardial no-reflow following percutaneous coronary intervention:a meta analysis[J].Chin Med J(Engl),2013,126(9):1755-1760.3174